CDC Advisory Panel To Take Up Booster Shot Debate
Newsy
An FDA advisory panel already rejected a sweeping White House plan to dispense boosters to all Americans.
An influential panel of advisers to the CDC convened on Wednesday to debate which Americans should get COVID-19 booster shots and when — a question that has proved more contentious than the Biden administration apparently expected.
The meeting came days after a different advisory group — this one serving the FDA — overwhelmingly rejected a sweeping White House plan to dispense third shots to nearly everyone. Instead, that panel endorsed booster doses of the Pfizer vaccine only for senior citizens and those at high risk from the virus.
While the COVID-19 vaccines continue to offer strong protection against severe illness, hospitalization and death, immunity against milder infection seems to be dropping months after vaccination.
